IABS Launches its North American Affiliate: IABS-NA

This is another landmark event in the history of lABS, and will open the way for greater participation on scientific activities with partners in Canada, Mexico, and the USA. The objectives of IABS-NA are to support the mission and projects of IABS, to enhance its image, and to develop an outreach within North America. IABS-NA will contribute to the scientific and medical advancement of biologicals by facilitating communication among those who develop, produce and regulate biological products for human and animal health. More specifically, it will focus on issues concerning the regulation and standardization of biological products that are intended for marketing within this region. As a neutral meeting point for the major stakeholders - regulators, academia, and industry- IABS-NA will consider the impact of regulatory requirements on innovation, with the objective of identifying issues that may require further consideration and possible modification.

Discussions are already underway regarding a conference topic that will meet that objective, and that will complement and enhance IABS-EU activities.

IABS-NA is officially recognized by USA authorities as a charitable organization [501(c)(3) designation].  


IABS-EU leads regulatory work package in the IMI Call Zoonosis Anticipation and Preparedness Initiative (ZAPI)

The Zoonoses Anticipation and Preparedness Initiative (ZAPI), part of the Innovative Medicines Initiative (IMI) public-private partnership, aims to enable swift response to major new infectious disease threats in Europe and throughout the world by designing new manufacturing processes (up to large scale) for delivering effective control tools (vaccines, antibodies/antibody-like molecules) against (re-)emerging zoonotic diseases with pandemic potential within a few months after the occurrence of first cases.

This, however, creates an unforeseen regulatory situation: how to proceed in an emergency situation?

In order to respond to this question, IABS-EU has become a facilitator in the elaboration of new regulatory processes. It has created a group of experts composed of regulatory agencies and members of the consortium to address specific issues in emergency situations to ensure that these new tools become quickly available.

ZAPI is a 5 years collaborative partnership between more than 20 European partners, including leading human and veterinary research institutions, non-governmental organizations, regulatory agencies, expert academic groups, and vaccine and biotech manufacturers. With more than 22 million euros in funding, ZAPI is the first true “One Health” project within the scope of IMI and unites experts in animal health and human health.


Harmonized Safety Monitoring of Immunization in Pregnancy

The important Harmonized Safety Monitoring of Immunization in Pregnancy International Consensus Conference was recently held at the NIH in Bethesda, Maryland and highlighted progress to date in harmonizing safety monitoring of immunization in pregnancy.

Learn more about the GAIA conference by visiting:
IABS Past Conferences

International Alliance for Biological Standardization

Twitter Feed

#IABS #HUMANCHALLENGETRIALS. #MyronLevine presents #HTCs Perspectives and Current Issues. Register at : https://t.co/f5eiaCgM2T
#IABS#AUTOGENOUSVACCINES and their role in #ANIMALHEALTHSTRATEGY: differences to minor markets/minor use(#MUMS) emergency-regular licensing
Follow IABS_global on Twitter

Contact Info

IABS, Rue de la Vallée, 3
CH-1204 Geneva

+ 41 22 301 10 36
+ 41 22 301 10 37
This email address is being protected from spambots. You need JavaScript enabled to view it.